Ginkgo Bioworks Holdings (DNA) Shares Outstanding (2019 - 2026)

Ginkgo Bioworks Holdings (DNA) has 8 years of Shares Outstanding (Entity) data on file, last reported at $65.1 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 12.01% year-over-year to $65.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.1 million (up 12.01% YoY) and the FY2025 annual result came in at $61.7 million, up 6.69% from the prior year.
• Shares Outstanding (Entity) climbed to $65.1 million in Q1 2026, from $61.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $65.1 million in Q1 2026 to a low of $48347.0 in Q1 2023.
• A 5-year average of $49.9 million and a median of $54.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) plunged 99.88% — and 2024, when it soared 112214.47%.
• Tracing DNA's Shares Outstanding (Entity) over 5 years: stood at $42.0 million in 2022, then advanced by 27.39% to $53.5 million in 2023, then grew by 8.12% to $57.8 million in 2024, then climbed by 6.69% to $61.7 million in 2025, then increased by 5.6% to $65.1 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $65.1 million (Q1 2026), $61.7 million (Q4 2025), and $60.3 million (Q3 2025), per Business Quant data.